School of Medicine

The Latest

UC San Diego’s Class of 2016 to Graduate June 11 and 12

More than 8,000 students of the University of California San Diego will graduate during the campus’s commencement weekend June 11 and 12, beginning with the All Campus Commencement featuring keynote speaker Muhammad Yunus, a Nobel Peace Prize recipient and founder of the global microfinance movement. The event, at 10 a.m. on Saturday, June 11, will mark the first time in 16 years that UC San Diego will convene all of its graduating undergraduate and graduate students for a campus-wide commencement ceremony.

Current Screening Methods Miss Worrisome Number of Persons with Mild Cognitive Impairment

In a paper published in the current Journal of Alzheimer’s Disease, researchers at University of California San Diego School of Medicine and Veterans Affairs San Diego Healthcare System say existing screening tools for mild cognitive impairment (MCI) result in a false-negative error rate of more than 7 percent. These persons are misclassified as not having MCI based on standard screening instruments but actually do have MCI when more extensive testing is conducted.

CIRM Grants May Fund the Next Great Stem Cell Achievement

All scientific achievement begins with an idea. Yesterday, three researchers at University of California San Diego School of Medicine were awarded funding by the Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) to pursue budding ideas that might eventually impact the field of human stem cell research.

New International Initiative Will Focus on Immunology Research and Treatments

Immunology – and the idea that many diseases can best be addressed by boosting the body’s own immune response – is one of the hottest areas in medical research and clinical treatment. University of California San Diego School of Medicine and Chiba University School of Medicine in Japan have announced a new collaborative research center to investigate the most promising aspects of immunology, especially the area of mucosal immunology, and to speed development of clinical applications.

High Levels of Protein p62 Predict Liver Cancer Recurrence

Researchers at University of California San Diego School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have discovered that high levels of the protein p62 in human liver samples are strongly associated with cancer recurrence and reduced patient survival. In mice, they also found that p62 is required for liver cancer to form.

UC San Diego Joins IBM World Community Grid’s Search for Zika Treatment

IBM's World Community Grid and scientists from Brazil, the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, and Rutgers New Jersey Medical School have launched OpenZika, a project to find drug candidates to treat Zika, a fast spreading virus that the World Health Organization has declared a global public health emergency.